Clinical Trial Update: Novel Evaluation With QGC001 in Hypertensive Overweight Patients of Multiple Ethnic Origins [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating QGC001 in hypertensive overweight patients of multiple ethnic origins has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• QGC001

Snippet

Sponsor: Quantum Genomics SA | Conditions: Hypertension | Phase 2 | Status: COMPLETED